News
Trial Confirms Treating Gout Based on Uric Acid Level, Not Symptoms
Basing the treatment of gout on reaching and maintaining target serum uric acid level is already endorsed in guidelines, but a randomized trial...
News
Low Infection Risk, Apart from Herpes Zoster, Seen in Real-World JAK Inhibitor Data for RA
The only infection risk in patients with RA that is higher with Janus kinase inhibitors relative to biologics is herpes zoster, according to...
News
Investigational MS Med Nearly Eliminates Disease Activity on MRI
Among those initially randomly assigned to receive 1200 mg every 4 weeks, 96% were free of new gadolinium-positive lesions at 48 weeks.
News
New TAVI Platform Adds More Valve Sizes to Choose From
New study finds intermediate valve sizes are comparable to standard sizes in safety and efficacy.
News
Pediatricians Face Competing Goals in Well Visits for LGBTQ+ Adolescents
Eliciting adolescent sexual orientation and gender identity is a delicate step.
News
More Rapid Confirmation of an Autism Diagnosis Is Coming to Primary Care
Poor outcome in autism linked to delayed diagnosis is driving change.
News
Follow-Up for Pediatric Depression Doubles With New Quality Initiative
In a cultural shift, pediatric clinic takes ownership of mental health outcomes.
News
Pediatrician Credibility Remains Intact in Midst of Health Misinformation
Pediatricians report high frequency of health misinformation but feel they are trusted.
News
The Inconsistency of Preparticipation Sports Evaluations Raises Issues About Their Utility
Preparticipation sports evaluations for children might need reconsideration.
News
Novel Treatment Options for Epilepsy
Three novel therapies for epilepsy, including a first-in-man product, are positive.
News
Pediatric Clinic Doubles Well-Visit Data Capture by Going Completely Paperless
Improved data capture is just one advantage of a comprehensive paperless approach.
News
In the Story of the Rubella Virus as a Source of Granulomas, the Plot Is Still Thickening
On dermatopathology, these commonly feature a robust granulomatous inflammation with multinucleated giant cells and lymphocytic infiltrate.
News
Approved Therapy for ALS Is Withdrawn When New Study Shows No Benefit
A newly completed trial has led to market withdrawal of the ALS therapy PB&TURSO.
News
Positive Results From Phase 2 Trial Support Potential New Option for Control of CIDP
Efgartigimod PC20 trial meets the primary endpoint with favorable safety profile.
News
BPH Trial Finds One Approach Clinically Superior
Procedure that lifts prostate tissue improved symptoms and patient satisfaction compared with tissue ablation.